Worth Venture Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Worth Venture Partners’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,820	Closed	-$60K	–	187
2018 Q3	$60K	Sell	4,820 -3,230	-40%	-$83K	0.05%	128
2018 Q2	$75K	Buy	8,050 +4,950	+160%	+$117K	0.06%	74
2018 Q1	$42K	Buy	+3,100	New	+$90.7K	0.04%	91

Worth Venture Partners's AVEO Position: Q1 2023 in Review

Worth Venture Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 170,925 shares — an estimated $2.56M sold.

Worth Venture Partners first reported a position in AVEO in Q1 2018 and held it in 7 quarters. The position peaked at $5.64M in Q3 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

Worth Venture Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
Worth Venture Partners sold 170,925 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $2.56M.
Worth Venture Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q1 2018 and held it in 7 quarters.
Worth Venture Partners's AVEO Pharmaceuticals, Inc. position peaked at $5.64M in Q3 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Worth Venture Partners's 13F filing for Q1 2023, filed 15 May 2023.